Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
488 | 15502 | 43.8 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
100 | 3 | NEUROSCIENCES//METABOTROPIC GLUTAMATE RECEPTOR//HIPPOCAMPUS | 73970 |
488 | 2 | SIGMA RECEPTOR//NMDA RECEPTOR//PHENCYCLIDINE | 15502 |
1378 | 1 | KAINATE RECEPTOR//CYCLOTHIAZIDE//AMPA RECEPTOR | 2691 |
2042 | 1 | NMDA RECEPTOR//NR2B//NR2A | 2376 |
3540 | 1 | SIGMA RECEPTOR//SIGMA1 RECEPTOR//SIGMA 1 RECEPTOR | 1962 |
5639 | 1 | HOMOCYSTEATE//2 AMINO 4 PHOSPHONOBUTANOIC ACID//BETA P CHLOROPHENYLGLUTAMATE | 1594 |
6033 | 1 | ARCAINE//POLYAMINES//SPERMINE | 1540 |
6946 | 1 | PHENCYCLIDINE//METAPHIT//BTCP | 1425 |
7778 | 1 | KETAMINE//EXPT THER EUT PATHOPHYSIOL BRANCH//INTEGRAT BIOMED BRAIN DIS | 1328 |
9910 | 1 | GLYT1//GLYCINE TRANSPORTER//GLYCINE TRANSPORTER INHIBITORS | 1108 |
16847 | 1 | MK 801//NMDA ANTAGONIST//POSTERIOR CINGULATE AND RETROSPLENIAL CORTICES | 632 |
19745 | 1 | MEMANTINE//AMANTADINE//UNCOMPETITIVE ANTAGONIST | 491 |
23200 | 1 | D CYCLOSERINE//MILACEMIDE//CYCLOSERINE | 355 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SIGMA RECEPTOR | authKW | 645859 | 3% | 78% | 423 |
2 | NMDA RECEPTOR | authKW | 536437 | 8% | 22% | 1236 |
3 | PHENCYCLIDINE | authKW | 316082 | 2% | 43% | 373 |
4 | KETAMINE | authKW | 231595 | 4% | 19% | 609 |
5 | D CYCLOSERINE | authKW | 219714 | 1% | 62% | 180 |
6 | GLUTAMATE RECEPTORS | authKW | 207347 | 3% | 20% | 520 |
7 | SIGMA1 RECEPTOR | authKW | 207186 | 1% | 90% | 117 |
8 | SIGMA 1 RECEPTOR | authKW | 204720 | 1% | 82% | 127 |
9 | KAINATE RECEPTOR | authKW | 201815 | 1% | 54% | 189 |
10 | NMDA | authKW | 152698 | 3% | 15% | 534 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 121893 | 51% | 1% | 7969 |
2 | Pharmacology & Pharmacy | 37327 | 30% | 1% | 4635 |
3 | Psychiatry | 10322 | 10% | 0% | 1589 |
4 | Chemistry, Medicinal | 8438 | 8% | 0% | 1177 |
5 | Behavioral Sciences | 3859 | 4% | 0% | 620 |
6 | Biochemistry & Molecular Biology | 1774 | 13% | 0% | 2086 |
7 | Clinical Neurology | 965 | 5% | 0% | 783 |
8 | Physiology | 878 | 4% | 0% | 563 |
9 | Substance Abuse | 558 | 1% | 0% | 170 |
10 | Chemistry, Organic | 261 | 4% | 0% | 565 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMAZEUT MED CHEM | 61744 | 1% | 31% | 100 |
2 | CELLULAR MOL NEUROPHYSIOL | 45378 | 0% | 47% | 49 |
3 | EXPT THER EUT PATHOPHYSIOL BRANCH | 32177 | 0% | 32% | 52 |
4 | CELLULAR PATHOBIOL SECT | 29726 | 0% | 66% | 23 |
5 | BEHAV NEUROPHARMACOL GRP | 29631 | 0% | 94% | 16 |
6 | FORENS MENTAL HLTH | 22969 | 0% | 20% | 59 |
7 | CELLULAR PATHOBIOL UNIT | 19240 | 0% | 65% | 15 |
8 | PHYSIOL CELLULAIRE SYN SE | 18199 | 0% | 51% | 18 |
9 | UNIT RECEPTOR BIOCHEM PHARMACOL | 16395 | 0% | 83% | 10 |
10 | U336 | 16161 | 0% | 34% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROPHARMACOLOGY | 45234 | 3% | 5% | 467 |
2 | EUROPEAN JOURNAL OF PHARMACOLOGY | 29925 | 4% | 2% | 663 |
3 | BRAIN RESEARCH | 22256 | 5% | 2% | 748 |
4 | JOURNAL OF NEUROCHEMISTRY | 20989 | 3% | 2% | 479 |
5 | NEUROSCIENCE LETTERS | 18234 | 4% | 2% | 548 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 13758 | 3% | 2% | 392 |
7 | JOURNAL OF NEUROSCIENCE | 12972 | 3% | 1% | 485 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 11185 | 2% | 2% | 358 |
9 | PSYCHOPHARMACOLOGY | 10259 | 2% | 2% | 256 |
10 | JOURNAL OF PSYCHEDELIC DRUGS | 9765 | 0% | 38% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIGMA RECEPTOR | 645859 | 3% | 78% | 423 | Search SIGMA+RECEPTOR | Search SIGMA+RECEPTOR |
2 | NMDA RECEPTOR | 536437 | 8% | 22% | 1236 | Search NMDA+RECEPTOR | Search NMDA+RECEPTOR |
3 | PHENCYCLIDINE | 316082 | 2% | 43% | 373 | Search PHENCYCLIDINE | Search PHENCYCLIDINE |
4 | KETAMINE | 231595 | 4% | 19% | 609 | Search KETAMINE | Search KETAMINE |
5 | D CYCLOSERINE | 219714 | 1% | 62% | 180 | Search D+CYCLOSERINE | Search D+CYCLOSERINE |
6 | GLUTAMATE RECEPTORS | 207347 | 3% | 20% | 520 | Search GLUTAMATE+RECEPTORS | Search GLUTAMATE+RECEPTORS |
7 | SIGMA1 RECEPTOR | 207186 | 1% | 90% | 117 | Search SIGMA1+RECEPTOR | Search SIGMA1+RECEPTOR |
8 | SIGMA 1 RECEPTOR | 204720 | 1% | 82% | 127 | Search SIGMA+1+RECEPTOR | Search SIGMA+1+RECEPTOR |
9 | KAINATE RECEPTOR | 201815 | 1% | 54% | 189 | Search KAINATE+RECEPTOR | Search KAINATE+RECEPTOR |
10 | NMDA | 152698 | 3% | 15% | 534 | Search NMDA | Search NMDA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TRAYNELIS, SF , WOLLMUTH, LP , MCBAIN, CJ , MENNITI, FS , VANCE, KM , OGDEN, KK , HANSEN, KB , YUAN, HJ , MYERS, SJ , DINGLEDINE, R , (2010) GLUTAMATE RECEPTOR ION CHANNELS: STRUCTURE, REGULATION, AND FUNCTION.PHARMACOLOGICAL REVIEWS. VOL. 62. ISSUE 3. P. 405 -496 | 770 | 59% | 934 |
2 | DINGLEDINE, R , BORGES, K , BOWIE, D , TRAYNELIS, SF , (1999) THE GLUTAMATE RECEPTOR ION CHANNELS.PHARMACOLOGICAL REVIEWS. VOL. 51. ISSUE 1. P. 7 -61 | 356 | 58% | 2659 |
3 | DANYSZ, W , PARSONS, CG , (1998) GLYCINE AND N-METHYL-D-ASPARTATE RECEPTORS: PHYSIOLOGICAL SIGNIFICANCE AND POSSIBLE THERAPEUTIC APPLICATIONS.PHARMACOLOGICAL REVIEWS. VOL. 50. ISSUE 4. P. 597 -664 | 464 | 62% | 465 |
4 | ROUSSEAUX, CG , GREENE, SF , (2016) SIGMA RECEPTORS [SIGMA RS]: BIOLOGY IN NORMAL AND DISEASED STATES.JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION. VOL. 36. ISSUE 4. P. 327 -388 | 476 | 49% | 1 |
5 | LEHMKUHL, K , JIA, H , WUNSCH, B , BRUST, P , DEUTHER-CONRAD, W , (2014) MOLECULAR IMAGING OF ALPHA(1) RECEPTORS IN VIVO: CURRENT STATUS AND PERSPECTIVES.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 1. P. 35 -69 | 228 | 84% | 14 |
6 | PAOLETTI, P , BELLONE, C , ZHOU, Q , (2013) NMDA RECEPTOR SUBUNIT DIVERSITY: IMPACT ON RECEPTOR PROPERTIES, SYNAPTIC PLASTICITY AND DISEASE.NATURE REVIEWS NEUROSCIENCE. VOL. 14. ISSUE 6. P. 383-400 | 132 | 68% | 363 |
7 | BANISTER, SD , KASSIOU, M , (2012) THE THERAPEUTIC POTENTIAL OF SIGMA (SIGMA) RECEPTORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES: EVALUATION OF THE EVIDENCE.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 7. P. 884 -901 | 215 | 89% | 19 |
8 | MAURICE, T , SU, TP , (2009) THE PHARMACOLOGY OF SIGMA-1 RECEPTORS.PHARMACOLOGY & THERAPEUTICS. VOL. 124. ISSUE 2. P. 195 -206 | 146 | 90% | 289 |
9 | COBOS, EJ , ENTRENA, JM , NIETO, FR , CENDAN, CM , DEL POZO, E , (2008) PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF SIGMA(1) RECEPTOR LIGANDS.CURRENT NEUROPHARMACOLOGY. VOL. 6. ISSUE 4. P. 344 -366 | 177 | 84% | 163 |
10 | JANE, DE , LODGE, D , COLLINGRIDGE, GL , (2009) KAINATE RECEPTORS: PHARMACOLOGY, FUNCTION AND THERAPEUTIC POTENTIAL.NEUROPHARMACOLOGY. VOL. 56. ISSUE 1. P. 90-113 | 170 | 88% | 120 |
Classes with closest relation at Level 2 |